Stay updated on Sacituzumab Govitecan in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T14:07:16.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T15:11:53.000Z thumbnail image
  3. Check
    33 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating the study details are temporarily unavailable; the UI shows a minimal 403 page with a header and navigation.
    Difference
    20%
    Check dated 2026-09-21T22:10:35.000Z thumbnail image
  4. Check
    47 days ago
    Change Detected
    Summary
    The study is no longer recruiting participants, and the total number of participating locations has decreased due to site removals.
    Difference
    3%
    Check dated 2026-09-07T20:29:18.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6 on the page. This indicates a new build/update of the page, with no substantive content changes implied.
    Difference
    0.0%
    Check dated 2026-08-31T16:20:09.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The study's external identifiers now include an NIH grant/contract entry for 2023, reflecting NIH funding attribution.
    Difference
    0.0%
    Check dated 2026-08-24T16:42:02.000Z thumbnail image

Stay in the know with updates to Sacituzumab Govitecan in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.